Home > Boards > US Listed > Biotechs > Akari Therapeutics (AKTX)

Lol!! Called him a few times myself, and

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BrazenBull Member Profile
 
Followed By 125
Posts 8,109
Boards Moderated 4
Alias Born 11/14/12
160x600 placeholder
Securities Registration (foreign Private Issuer) (f-1) Edgar (US Regulatory) - 10/15/2019 5:24:28 PM
Securities Registration (ads, Immediate) (f-6ef) Edgar (US Regulatory) - 10/15/2019 5:09:46 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/15/2019 7:08:47 AM
Akari Therapeutics Announces New Data from Atopic Keratoconjunctivitis (AKC) Patients Supporting the Potentially Beneficial R... GlobeNewswire Inc. - 10/14/2019 8:37:28 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/10/2019 9:03:34 AM
Akari Therapeutics Announces Positive Phase II Clinical Data in Orphan Blistering Skin Disease Bullous Pemphigoid at the 28th... GlobeNewswire Inc. - 10/10/2019 8:45:02 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/4/2019 4:48:17 PM
Akari Therapeutics to Participate in Ladenburg Thalmann Healthcare Conference GlobeNewswire Inc. - 9/18/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/13/2019 8:17:32 AM
Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Bullous Pemphigoid GlobeNewswire Inc. - 9/13/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/10/2019 8:22:04 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/9/2019 6:01:20 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/6/2019 5:08:04 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/6/2019 6:01:28 AM
Akari Therapeutics to Participate in Citi and H.C. Wainwright Conferences in Early September GlobeNewswire Inc. - 9/3/2019 7:00:00 AM
Securities Registration (foreign Private Issuer) (f-1/a) Edgar (US Regulatory) - 8/30/2019 4:04:38 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 8/30/2019 4:02:20 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/30/2019 8:13:13 AM
Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Hematopoietic Stem Cell Transplantation-Associated T... GlobeNewswire Inc. - 8/30/2019 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/29/2019 8:29:12 AM
Akari Therapeutics Reports Second Quarter 2019 Financial Results And Highlights Recent Clinical Progress GlobeNewswire Inc. - 8/29/2019 8:06:18 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/19/2019 4:05:56 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/14/2019 8:01:05 AM
Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for Pediatric Hematopoietic Stem Cell Transplant-Related... GlobeNewswire Inc. - 8/14/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/9/2019 8:53:15 AM
BrazenBull   Thursday, 08/16/18 08:32:34 PM
Re: makingbiigdough post# 206
Post # of 474 
Lol!! Called him a few times myself, and can concur he doesn’t phone back. BC is awesome and you should bring your fam out! Guess we will keep holding. Eventually she is run hard. Real hard

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist